Fatima Al Kaabi
Tracked across 1 events · 6 articles · First seen Dec 20, 2025 · Last active Jun 02, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Fatima Al Kaabi, Director-General of the United Arab Emirates — Emirates Drug Establishment, stated that the approval of Onasemnogene abeparvovec is a significant step demonstrating the United Arab Emirates' commitment to providing patients with advanced genetic therapies.
Dec 20, 2025 · 6 articles
ERGEN INTELLIGENCE
Track Fatima Al Kaabi live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard